EE9900320A - Uus inhaleeritav budesoniidi sisaldav ravimvorm puistetihedusega 0,28 kuni 0,38 g/ml - Google Patents

Uus inhaleeritav budesoniidi sisaldav ravimvorm puistetihedusega 0,28 kuni 0,38 g/ml

Info

Publication number
EE9900320A
EE9900320A EEP199900320A EEP9900320A EE9900320A EE 9900320 A EE9900320 A EE 9900320A EE P199900320 A EEP199900320 A EE P199900320A EE P9900320 A EEP9900320 A EE P9900320A EE 9900320 A EE9900320 A EE 9900320A
Authority
EE
Estonia
Prior art keywords
bulk density
budesonide formulation
inhaled budesonide
formulation
new inhaled
Prior art date
Application number
EEP199900320A
Other languages
English (en)
Inventor
Trofast Jan
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20405452&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE9900320(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of EE9900320A publication Critical patent/EE9900320A/et
Publication of EE03998B1 publication Critical patent/EE03998B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EEP199900320A 1997-01-20 1998-01-13 Inhaleeritav budesoniidi sisaldav ravimvorm puistetihedusega 0,28 kuni 0,38 g/ml EE03998B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9700133A SE9700133D0 (sv) 1997-01-20 1997-01-20 New formulation
PCT/SE1998/000038 WO1998031350A1 (en) 1997-01-20 1998-01-13 New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml, comprising budesonide

Publications (2)

Publication Number Publication Date
EE9900320A true EE9900320A (et) 2000-02-15
EE03998B1 EE03998B1 (et) 2003-04-15

Family

ID=20405452

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900320A EE03998B1 (et) 1997-01-20 1998-01-13 Inhaleeritav budesoniidi sisaldav ravimvorm puistetihedusega 0,28 kuni 0,38 g/ml

Country Status (35)

Country Link
US (1) US6027714A (et)
EP (1) EP1019033B1 (et)
JP (1) JP2010059179A (et)
KR (1) KR100528418B1 (et)
CN (1) CN1222282C (et)
AT (1) ATE389390T1 (et)
AU (1) AU726916B2 (et)
BE (1) BE1011400A5 (et)
BR (1) BR9806892A (et)
CA (1) CA2277914C (et)
CZ (1) CZ295083B6 (et)
DE (1) DE69839275T2 (et)
DK (1) DK1019033T3 (et)
EE (1) EE03998B1 (et)
ES (2) ES2302348T3 (et)
FR (1) FR2759908B1 (et)
GR (1) GR1003290B (et)
HK (1) HK1025516A1 (et)
HU (1) HU228312B1 (et)
ID (1) ID22883A (et)
IE (1) IE980024A1 (et)
IL (1) IL130840A (et)
IS (1) IS2563B (et)
NL (1) NL1008019C2 (et)
NO (1) NO327451B1 (et)
NZ (1) NZ336592A (et)
PL (1) PL191569B1 (et)
PT (1) PT1019033E (et)
RU (1) RU2180563C2 (et)
SE (1) SE9700133D0 (et)
SI (1) SI1019033T1 (et)
SK (1) SK283948B6 (et)
TR (1) TR199901691T2 (et)
UA (1) UA57762C2 (et)
WO (1) WO1998031350A1 (et)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9803770D0 (sv) * 1998-11-05 1998-11-05 Astra Ab Dry powder pharmaceutical formulation
EP1129705A1 (en) 2000-02-17 2001-09-05 Rijksuniversiteit te Groningen Powder formulation for inhalation
GB0008660D0 (en) * 2000-04-07 2000-05-31 Arakis Ltd The treatment of respiratory diseases
GB0012261D0 (en) * 2000-05-19 2000-07-12 Astrazeneca Ab Novel process
FR2809692A1 (fr) 2000-05-31 2001-12-07 Ecia Equip Composants Ind Auto Ensemble de masquage d'un coussin gonflable de securite pour vehicule automobile, procede de fabrication et planche de bord correspondante
US20020141946A1 (en) * 2000-12-29 2002-10-03 Advanced Inhalation Research, Inc. Particles for inhalation having rapid release properties
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
US6681768B2 (en) 2001-06-22 2004-01-27 Sofotec Gmbh & Co. Kg Powder formulation disintegrating system and method for dry powder inhalers
US7931022B2 (en) * 2001-10-19 2011-04-26 Respirks, Inc. Method and apparatus for dispensing inhalator medicament
SE0200657D0 (sv) * 2002-03-04 2002-03-04 Astrazeneca Ab Novel Formulation
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
US20070020298A1 (en) * 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
CN100333727C (zh) * 2004-11-25 2007-08-29 天津药业研究院有限公司 布地奈德靶向微丸及其制备方法
ES2493641T3 (es) * 2007-06-28 2014-09-12 Cydex Pharmaceuticals, Inc. Administración nasal de soluciones acuosas de corticosteroides
DE102007049931A1 (de) 2007-10-18 2009-04-23 Pharmatech Gmbh Vorrichtung und Verfahren zur kontinuierlichen Herstellung von sphärischen Pulveragglomeraten
WO2011110852A1 (en) 2010-03-10 2011-09-15 Astrazeneca Ab Polymorphic forms of 6- [2- (4 -cyanophenyl) - 2h - pyrazol - 3 - yl] - 5 -methyl - 3 - oxo - 4 - (trifluoromethyl - phenyl) 3,4-dihydropyrazine-2-carboxylic acid ethylamide
EP2821061B1 (en) 2013-07-01 2017-12-20 Arven Ilac Sanayi Ve Ticaret A.S. Novel inhalation formulations
AU2018318123B2 (en) 2017-08-15 2024-07-25 Nephron Pharmaceuticals Corporation Aqueous nebulization composition
EP4034079A1 (en) 2019-09-24 2022-08-03 Chiesi Farmaceutici S.p.A. Novel carrier particles for dry powder formulations for inhalation

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1429184A (en) * 1972-04-20 1976-03-24 Allen & Hanburys Ltd Physically anti-inflammatory steroids for use in aerosols
GB1571629A (en) * 1977-11-30 1980-07-16 Fisons Ltd Pharmaceutical compositions containing beclomethasone dipropionate
SE438261B (sv) * 1981-07-08 1985-04-15 Draco Ab Anvendning i dosinhalator av ett perforerat membran
EP0069715B1 (en) * 1981-07-08 1986-11-05 Aktiebolaget Draco Powder inhalator
EP0072046B1 (en) * 1981-07-24 1986-01-15 FISONS plc Inhalation drugs, methods for their production and pharmaceutical formulations containing them
ATE224748T1 (de) * 1989-04-28 2002-10-15 Riker Laboratories Inc Inhalationsvorrichtung für trockenpulver
US5176132A (en) * 1989-05-31 1993-01-05 Fisons Plc Medicament inhalation device and formulation
US5192548A (en) * 1990-04-30 1993-03-09 Riker Laboratoires, Inc. Device
SE9100341D0 (sv) * 1991-02-04 1991-02-04 Astra Ab Novel steroids
SE9100342D0 (sv) * 1991-02-04 1991-02-04 Astra Ab Novel steroid esters
SE9302777D0 (sv) * 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
SE9101090D0 (sv) * 1991-04-11 1991-04-11 Astra Ab Process for conditioning of water-soluble substances
ATE246497T1 (de) * 1991-06-10 2003-08-15 Schering Corp Fluorchlorkohlenwasserstoffreie aerosolformulierungen
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
CZ288032B6 (cs) * 1991-12-18 2001-04-11 Aktiebolaget Astra Farmaceutický prostředek pro podání inhalací
US5355872B1 (en) * 1992-03-04 1998-10-20 John H Riggs Low flow rate nebulizer apparatus and method of nebulization
GB2269992A (en) * 1992-08-14 1994-03-02 Rh Ne Poulenc Rorer Limited Powder inhalation formulations
EP0665010B1 (en) * 1992-10-16 2002-09-11 Nippon Shinyaku Company, Limited Method of manufacturing wax matrices
IL111080A (en) * 1993-10-01 1999-08-17 Astra Ab Method for treating a finely divided powder medicament
IS1736B (is) * 1993-10-01 1999-12-30 Astra Ab Aðferð og tæki sem stuðla að aukinni samloðun agna
DE4425255A1 (de) * 1994-07-16 1996-01-18 Asta Medica Ag Formulierung zur inhalativen Applikation
WO1996009814A1 (en) * 1994-09-29 1996-04-04 Andaris Limited Spray-dried microparticles as therapeutic vehicles
US5647347A (en) * 1994-10-21 1997-07-15 Glaxo Wellcome Inc. Medicament carrier for dry powder inhalator
US5503869A (en) * 1994-10-21 1996-04-02 Glaxo Wellcome Inc. Process for forming medicament carrier for dry powder inhalator
RU2071317C1 (ru) * 1994-12-21 1997-01-10 Александр Григорьевич Чучалин Лекарственный порошкообразный препарат для ингаляций
US5654007A (en) * 1995-06-07 1997-08-05 Inhale Therapeutic Systems Methods and system for processing dispersible fine powders
SE9603669D0 (sv) * 1996-10-08 1996-10-08 Astra Ab New combination

Also Published As

Publication number Publication date
HU228312B1 (en) 2013-03-28
GR980100021A (el) 1998-09-30
CZ255599A3 (cs) 1999-10-13
EE03998B1 (et) 2003-04-15
ES2148059B1 (es) 2001-04-01
NO327451B1 (no) 2009-07-06
TR199901691T2 (xx) 1999-09-21
IL130840A (en) 2005-03-20
FR2759908B1 (fr) 2000-04-21
JP4512202B2 (ja) 2010-07-28
HUP0000841A3 (en) 2001-01-29
IS5110A (is) 1999-07-06
NZ336592A (en) 2001-01-26
EP1019033A1 (en) 2000-07-19
ES2148059A1 (es) 2000-10-01
CZ295083B6 (cs) 2005-05-18
CN1222282C (zh) 2005-10-12
KR100528418B1 (ko) 2005-11-16
PL334493A1 (en) 2000-02-28
ATE389390T1 (de) 2008-04-15
IE980024A1 (en) 1998-10-07
EP1019033B1 (en) 2008-03-19
UA57762C2 (uk) 2003-07-15
CA2277914C (en) 2006-08-29
PT1019033E (pt) 2008-05-13
GR1003290B (el) 2000-01-03
BE1011400A5 (fr) 1999-08-03
SK283948B6 (sk) 2004-05-04
RU2180563C2 (ru) 2002-03-20
NL1008019C2 (nl) 1998-12-16
SE9700133D0 (sv) 1997-01-20
IL130840A0 (en) 2001-01-28
DE69839275D1 (de) 2008-04-30
DK1019033T3 (da) 2008-06-09
CA2277914A1 (en) 1998-07-23
NO993537D0 (no) 1999-07-19
DE69839275T2 (de) 2009-04-02
WO1998031350A1 (en) 1998-07-23
FR2759908A1 (fr) 1998-08-28
ID22883A (id) 1999-12-16
NO993537L (no) 1999-09-17
HUP0000841A2 (hu) 2000-10-28
NL1008019A1 (nl) 1998-07-22
PL191569B1 (pl) 2006-06-30
SK95799A3 (en) 2000-01-18
BR9806892A (pt) 2000-05-16
HK1025516A1 (en) 2000-11-17
IS2563B (is) 2009-12-15
AU5785798A (en) 1998-08-07
CN1243434A (zh) 2000-02-02
ES2302348T3 (es) 2008-07-01
SI1019033T1 (sl) 2008-08-31
JP2001509811A (ja) 2001-07-24
KR20000070186A (ko) 2000-11-25
US6027714A (en) 2000-02-22
JP2010059179A (ja) 2010-03-18
AU726916B2 (en) 2000-11-23

Similar Documents

Publication Publication Date Title
MY132999A (en) New formulation for inhalation
EE9900320A (et) Uus inhaleeritav budesoniidi sisaldav ravimvorm puistetihedusega 0,28 kuni 0,38 g/ml
EE9900294A (et) Uus inhaleeritav formoterooli sisaldav ravimvorm puistetihedusega 0,28 kuni 0,38 g/ml
EE9900293A (et) Uus inhaleeritav terbutaliinsulfaati sisaldav ravimvorm puistetihedusega 0,28 kuni 0,38 g/ml, selle valmistamise protsess ja kasutamine

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

KB4A Valid patent at the end of a year

Effective date: 20101231